SCHEMBL4833207

SCHEMBL4833207

NC1c2ccoc2N=CN1c1ccc(NS(=O)(=O)c2ccc(Oc3ccccn3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.40
▸ MMP2 P08253 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.37
▸ MMP1 P03956 1/20 0.37
▸ MMP13 P45452 1/20 0.37
▸ PGR P06401 4/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ BRAF P15056 1/20 0.36
▸ FFAR1 O14842 2/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.36
▸ GRM4 Q14833 1/20 0.36
▸ NPY5R Q15761 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4836849 0.87 PGR (0.37) LMNAMMP2MMP9TSHRHTT
SCHEMBL4833953 0.84 PKM (0.44) LMNAPGRALDH1A1NPY5RMEN1
SCHEMBL4831477 0.84 ALDH1A1 (0.48) LMNATSHRHTTSMN1; SMN2KDM4E
SCHEMBL4834514 0.83 PGR (0.43) PGRFFAR1FFAR4MAPTKMT2A
SCHEMBL4831418 0.82 PGR (0.45) LMNAHTTPGRALDH1A1FFAR1
SCHEMBL4834296 0.82 SMN1; SMN2 (0.47) LMNATSHRHTTSMN1; SMN2ALDH1A1
SCHEMBL4836678 0.81 TP53 (0.46) SMN1; SMN2ALDH1A1FFAR4NPY5RMAPT
SCHEMBL4834410 0.81 CA1 (0.47) LMNAHTTSMN1; SMN2ALDH1A1FFAR1
SCHEMBL4825767 0.81 KMT2A (0.48) LMNAHTTALDH1A1MEN1MAPT
SCHEMBL4829094 0.79 PGR (0.46) PGRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US claimed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US claimed
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF ADAMS JERRY LEROY 2008-11-20 — — US disclosed
US-7427623-B2 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof SMITHKLINE BEECHAM CORPORATION (US) 2008-09-23 — — US disclosed
US-20050004142-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2005-01-06 — — US disclosed
EP-1425284-A2 FURO- AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-06-09 — — EP disclosed
WO-2003022852-A2 FURO-AND THIENOPYRIMIDINE DERIVATIVES AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-03-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004142-A1 Chemical compounds TIE1, KDR, TEK LMNA 4230/4885MMP2 3994/4885MMP9 2821/4885
US-20080287466-A1 4-AMINO-2,3-DISUBSTITUTED THIENO [2,3,D]PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF TIE1, TEK, KDR LMNA 4131/4885MMP2 4434/4885MMP9 3692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback